[{"Assets_0_FY_USD":4690039000.0,"CommonStockSharesConverted_0_FY_shares":179838114.0,"CommonStockSharesOutstanding_0_FY_shares":179838114.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":48262000.0,"NetIncomeLossConverted_4_FY_USD":-23848000.0,"StockholdersEquity_0_FY_USD":3122381000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":179039000.0,"EarningsPerShareBasic_4_FY_USD":-0.13,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":179039000.0,"EarningsPerShareDiluted_4_FY_USD":-0.13,"RevenuesConverted_4_FY_USD":1704048000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200227"}]